Search
Print Page   |   Contact Us   |   Sign In   |   Join Today
Virginia Bioscience Commercialization Luncheon - Oct 2015
Tell a Friend About This EventTell a Friend
 

Monthly statewide bioscience luncheon held in Richmond, VA.

10/15/2015
When: Thursday, Oct 15
11:30 AM - 1:30 PM
Where: Virginia Biotechnology Research Park
800 E. Leigh St.
Richmond, Virginia  23227
United States
Contact: Liz Kelly
804-643-6360


Online registration is closed.
« Go to Upcoming Event List  

 

The Catalyst: Raising Capital to Accelerate Commercialization of University Technologies through High-Powered Collaboration

 

 

The Virginia Bioscience Health Research Corporation (the “Catalyst”) is an innovative, non-profit entity, created by the Commonwealth to accelerate commercialization of breakthrough technologies from our research universities that improve human health and drive economic development in Virginia. This is achieved by incentivizing Virginia's research universities to work together and to work with industry to achieve competitive critical mass through collaborations that attracts new capital from sources both inside and outside Virginia. VBHRC provides grants to projects that: 1) include a substantive collaboration among two or more of Virginia public research universities and industry partners; 2) address major unmet medical needs that will improve human health; 3) have national and global competitive advantages including IP protection; 4) have matching funds and 5) can demonstrate significant positive impact potential for economic development in Virginia.

 

Nearly a dozen grants have been made to competitively judged projects across the state, and across fields and disciplines in the biosciences. The CEO of the Catalyst and leaders of select collaborations which have received grants will share important research breakthroughs, successes in follow-on financing, report on progress in commercializing their technologies, provide return on investment data and summarize the impact of this innovative public policy initiative.

  

Please join us in this panel discussion which will include significant participation from attendees. If you are a research scientist who wants to commercialize your technologies, an entrepreneur, venture capitalist or a public policy influencer or decision maker you should attend this session. This session is expected to sell out, so please register early.

 

Panelists include:

Dr. Gautam Ghatnekar, President and CEO, FirstString Research, Inc.

Robert G. Gourdie Ph.D., Professor and Commonwealth Research Commercialization Fund Eminent Scholar, VTCRI, Director of the Center for Heart and Regenerative Medicine, VTCRI, Director of Emergency Medicine Research, Carilion Clinic, Professor; Virginia Tech Wake Forest University School of Biomedical Engineering and Sciences 

Michael Grisham, President & CEO, Virginia Biosciences Health Research Corporation 

Jerry L. Nadler, MD, FAHA, MACP, Harry H. Mansbach Professor and Chair, Department of Medicine, Vice Dean for Research, Eastern Virginia Medical School 

Emanuel "Chip" Petricoin Ph.D., University Professor, Co-Director Center for Applied Proteomics and Molecular Medicine, School of Systems Biology George Mason University 

Alan K. Smith, Ph.D., VP of R&D and Cellular Therapeutics, LifeNet Health Institute of Regenerative Medicine 

Brian Wamhoff, Ph.D., Co-founder and VP of R&D, HemoShear Therapeutics 

 Unable to come?  We will be live streaming the program at www.livestream.com/vabio.
 

Sponsors:


  

 

      

more Events

9/29/2016
MDMA 2016 Medical Technology Executive Forum

9/29/2016
Women Building Bio: The XX Factor

Premium Members

Membership Software Powered by YourMembership.com®  ::  Legal